Leerink Partners Adjusts Moderna Price Target to $27 From $31, Maintains Underperform Rating

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.99 USD | +3.35% |
|
+1.20% | -20.66% |
Feb. 14 | Health Care Down as Moderna Shares Slide -- Health Care Roundup | DJ |
Feb. 14 | Moderna Reports Another Quarterly Loss | MT |